Stool Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast 2024-2028

Published: Oct 2023 Pages: 165 SKU: IRTNTR74310

Stool Testing Market 2024-2028

The Stool Testing Market size is estimated to grow by USD 445.95 million at a CAGR of 5.92% between 2023 and 2028. 

Key Findings:

  • Stool testing market remained historically at high levels from 2018 to 2023.
  • The market is segmented into Type, End-user, and Geography.
  • GI sub segment under the Type segment generated the largest revenue in 2018.
  • Key regions boosting the market growth include North America, Europe, Asia, and Rest of World (ROW).

Stool testing market Share

For More Highlights About this Report, Download Free Sample in a Minute 

Stool Testing Market: Key Drivers, Trends and Challenges

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Stool Testing Market Driver

One of the key factors driving the stool testing market growth is the increasing prevalence of CRC. One of the most common cancers prevailing across the globe is CRC. In addition, several factors that can possibly increase an individual risk of CRC include overweight or obesity, lack of physical activity, smoking, excessive alcohol consumption, unhealthy food intake, personal history of being encountered with colorectal polyps, and inflammatory bowel disease, family history of adenomatous polyps, and type 2 diabetes.

Moreover, certain genetic conditions such as Lynch syndrome, Turcot syndrome, Muir-Torre syndrome, and juvenile polyposis syndrome have significantly increased the risk of CRC and other types of cancer. In addition, to reduce the CRC mortality rate, several screening tests, including FOBT, stool DNA test, flexible sigmoidoscopy, colonoscopy, and imaging scans, are being performed across the world with the help of government and healthcare organizations. Hence, such factors are driving the market growth during the forecast period.

Key Stool Testing Market Trends

A key factor shaping the stool testing market growth is the growing demand for point-of-care testing. The successful reduction in the mortality rates of CRC needs early diagnosis, early initiation of treatment, and accurate screening of individuals who are at risk of CRC. Hence, to perform these tasks, an efficient and sensitive assay is required to increase CRC screening efforts in various healthcare settings.

Moreover, the introduction of POC testing has improved the way diagnostics and clinical procedures are being performed. In addition, early diagnosis and accurate treatment of the disease are the most important strategies implemented by various stakeholders, as early detection of low-grade CRC increases the likelihood of survival, which relies on the patient's age. Therefore, technological advances in the form of low-cost rapid POC tests have transformed the diagnosis and treatment of CRC. Hence, such factors drive the market growth during the forecast period.

Major Stool Testing Market Challenge

High treatment costs associated with GI disorders and colorectal cancer are one of the key challenges hindering the stool testing market growth. Even though the global stool testing market is growing at a rapid pace, the high costs associated with the devices used for diagnoses, such as stool testing kits and treatment of GI bleeding will negatively impact the market, especially in price-sensitive markets such as developing and emerging economies. In addition, even in developed countries, small hospitals and private physician clinics may not opt for endoscopic kits due to budget constraints.

Moreover, endoscopic kits are expensive and classified as capital items by healthcare institutions. In addition, the procurement of endoscopic devices involves many procedures and various budget allocation considerations before making the purchasing decision. Hence, such factors are negatively impacting the market. Therefore, it is expected to hinder the market growth during the forecast period.

Stool Testing Market Segmentations

Type Analysis

The GI segment is estimated to witness significant growth during the forecast period. GI stool testing can be referred to as a diagnosis of digestive tract disorder, which looks for gastrointestinal disorders that appear in the stool. In addition, stool testing utilizes stool cultures to help identify pathogens (bacteria, viruses, microorganisms) present in the GI tract that cause GI distress and other systemic symptoms.

Get a glance at the market contribution of various segments Download the PDF Sample

The GI segment was the largest segment and was valued at USD 643.40 million in 2018. Moreover, some of the findings through GI stool testing include digestion of food, types of bacteria in the gut, presence of dysbiosis, presence of parasites/worms, and strength of the immune system. In addition, some of the various reasons for GI stool testing, include hemorrhoids, peptic ulcers, inflammation in the esophagus, diverticulosis and diverticulitis, ulcerative colitis and Crohn's disease, colonic polyps, or cancer in the colon, stomach, or esophagus. Hence, factors such as the the increasing prevalence of chronic diseases coupled with the growing geriatric population fuels the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. There has been an increase in the adoption of various advanced technologies for the treatment of GI bleeding in North America over the last few years. In addition, several factors such as the high adoption of technology, increasing prevalence and incidences of GI diseases, growing geriatric population, availability of reimbursement policies for endoscopic procedures, and the growing presence of prominent companies that develop endoscopic devices are significantly contributing to the growth of the market in the region.  Furthermore, the increasing prevalence of chronic diseases such as stomach cancer, colon cancer, and pancreatic cancer fuels the need for GI bleeding treatment. Hence, such factors drive market growth in North America during the forecast period.

Key Companies in Stool Testing Market

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

BioMerieux SA: The company offers stool testing device which is designed to implement sample preparation for nucleic acid extraction of viruses, bacteria, and parasites

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • AdvaCare Pharma
  • Cardinal Health Inc.
  • Cenogenics Corp.
  • Danaher Corp.
  • DiaSorin SpA
  • Eiken Chemical Co. Ltd.
  • Epitope Diagnostics Inc.
  • Exact Sciences Corp.
  • Genova Diagnostics Inc.
  • Helena Laboratories Corp.
  • Hologic Inc.
  • McKesson Corp.
  • Meridian Bioscience Inc.
  • Pinnacle BioLabs
  • Polymedco CDP LLC
  • Quest Diagnostics Inc.
  • Quidelortho Corp.
  • CTK Biotech Inc.
  • ScheBo Biotech AG

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Stool Testing Market Scope

Report Coverage

Details

Page number

165

Base year

2023

Historic period

 2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.92%

Market growth 2024-2028

USD 445.95 million

Market structure

Fragmented

YoY growth 2023-2024(%)

5.41

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 40%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

AdvaCare Pharma, bioMerieux SA, Cardinal Health Inc., Cenogenics Corp., Danaher Corp., DiaSorin SpA, Eiken Chemical Co. Ltd., Epitope Diagnostics Inc., Exact Sciences Corp., Genova Diagnostics Inc., Helena Laboratories Corp., Hologic Inc., McKesson Corp., Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco CDP LLC, Quest Diagnostics Inc., Quidelortho Corp., CTK Biotech Inc., and ScheBo Biotech AG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download PDF Sample

What are the Key Data Covered in this Stool Testing Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2024 and 2028
  • Precise estimation of the size of the market  size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global stool testing market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global stool testing market 2018 - 2022 ($ million)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ million)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 GI - Market size and forecast 2023-2028
      • Exhibit 34: Chart on GI - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on GI - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on GI - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on GI - Year-over-year growth 2023-2028 (%)
    • 6.4 Fecal occult - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Fecal occult - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Fecal occult - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Fecal occult - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Fecal occult - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ million)
      • Exhibit 43: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Diagnostic centres and laboratories - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
    • 7.5 Clinics and others - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Clinics and others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Clinics and others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Clinics and others - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Clinics and others - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ million)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 Germany - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 bioMerieux SA
              • Exhibit 111: bioMerieux SA - Overview
              • Exhibit 112: bioMerieux SA - Product / Service
              • Exhibit 113: bioMerieux SA - Key news
              • Exhibit 114: bioMerieux SA - Key offerings
            • 12.4 Cardinal Health Inc.
              • Exhibit 115: Cardinal Health Inc. - Overview
              • Exhibit 116: Cardinal Health Inc. - Business segments
              • Exhibit 117: Cardinal Health Inc. - Key news
              • Exhibit 118: Cardinal Health Inc. - Key offerings
              • Exhibit 119: Cardinal Health Inc. - Segment focus
            • 12.5 Cenogenics Corp.
              • Exhibit 120: Cenogenics Corp. - Overview
              • Exhibit 121: Cenogenics Corp. - Product / Service
              • Exhibit 122: Cenogenics Corp. - Key offerings
            • 12.6 CTK Biotech Inc.
              • Exhibit 123: CTK Biotech Inc. - Overview
              • Exhibit 124: CTK Biotech Inc. - Product / Service
              • Exhibit 125: CTK Biotech Inc. - Key offerings
            • 12.7 Danaher Corp.
              • Exhibit 126: Danaher Corp. - Overview
              • Exhibit 127: Danaher Corp. - Business segments
              • Exhibit 128: Danaher Corp. - Key news
              • Exhibit 129: Danaher Corp. - Key offerings
              • Exhibit 130: Danaher Corp. - Segment focus
            • 12.8 DiaSorin SpA
              • Exhibit 131: DiaSorin SpA - Overview
              • Exhibit 132: DiaSorin SpA - Business segments
              • Exhibit 133: DiaSorin SpA - Key news
              • Exhibit 134: DiaSorin SpA - Key offerings
              • Exhibit 135: DiaSorin SpA - Segment focus
            • 12.9 Eiken Chemical Co. Ltd.
              • Exhibit 136: Eiken Chemical Co. Ltd. - Overview
              • Exhibit 137: Eiken Chemical Co. Ltd. - Product / Service
              • Exhibit 138: Eiken Chemical Co. Ltd. - Key offerings
            • 12.10 Epitope Diagnostics Inc.
              • Exhibit 139: Epitope Diagnostics Inc. - Overview
              • Exhibit 140: Epitope Diagnostics Inc. - Product / Service
              • Exhibit 141: Epitope Diagnostics Inc. - Key offerings
            • 12.11 Genova Diagnostics Inc.
              • Exhibit 142: Genova Diagnostics Inc. - Overview
              • Exhibit 143: Genova Diagnostics Inc. - Product / Service
              • Exhibit 144: Genova Diagnostics Inc. - Key offerings
            • 12.12 Helena Laboratories Corp.
              • Exhibit 145: Helena Laboratories Corp. - Overview
              • Exhibit 146: Helena Laboratories Corp. - Product / Service
              • Exhibit 147: Helena Laboratories Corp. - Key offerings
            • 12.13 Hologic Inc.
              • Exhibit 148: Hologic Inc. - Overview
              • Exhibit 149: Hologic Inc. - Business segments
              • Exhibit 150: Hologic Inc. - Key news
              • Exhibit 151: Hologic Inc. - Key offerings
              • Exhibit 152: Hologic Inc. - Segment focus
            • 12.14 McKesson Corp.
              • Exhibit 153: McKesson Corp. - Overview
              • Exhibit 154: McKesson Corp. - Business segments
              • Exhibit 155: McKesson Corp. - Key offerings
              • Exhibit 156: McKesson Corp. - Segment focus
            • 12.15 Meridian Bioscience Inc.
              • Exhibit 157: Meridian Bioscience Inc. - Overview
              • Exhibit 158: Meridian Bioscience Inc. - Business segments
              • Exhibit 159: Meridian Bioscience Inc. - Key offerings
              • Exhibit 160: Meridian Bioscience Inc. - Segment focus
            • 12.16 Quidelortho Corp.
              • Exhibit 161: Quidelortho Corp. - Overview
              • Exhibit 162: Quidelortho Corp. - Product / Service
              • Exhibit 163: Quidelortho Corp. - Key offerings
            • 12.17 ScheBo Biotech AG
              • Exhibit 164: ScheBo Biotech AG - Overview
              • Exhibit 165: ScheBo Biotech AG - Product / Service
              • Exhibit 166: ScheBo Biotech AG - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 167: Inclusions checklist
                • Exhibit 168: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 169: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 170: Research methodology
                • Exhibit 171: Validation techniques employed for market sizing
                • Exhibit 172: Information sources
              • 13.5 List of abbreviations
                • Exhibit 173: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              stool testing market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis